Development of functional antibody assays to assess the immunogenicity of pertussis-containing vaccine (Tdap) for HIV-infected and HIV-uninfected pregnant women and their newborns, and a randomized clinical trial to assess the impact of maternal pertussis immunization on pregnancy outcome and child health.
View the (pre-published) study protocol here and clinical trial registration here.